Concepedia

Charles Ginther

CG

Statistics

Publications

34

Citations

4.9K

H-Index

26

Active since

1974

Affiliations

University of California, Los Angeles(Current)

University of California, Berkeley

Pfizer (United States)

Mayo Clinic

University of California, Davis

Charles Ginther is an author at University of California, Los Angeles specializing in medicine, molecular oncology, and oncology.

Publications per year

1974–2018

34

Publications

34

PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro

Richard S. Finn, Judy Dering, Dylan Conklin et al. · Breast Cancer Research · 2009 · 1.4K citations · Full text

, , +17

Prognostic and Therapeutic Relevance of Molecular Subtypes in High-Grade Serous Ovarian Cancer

Gottfried E. Konecny, Chen Wang, Habib Hamidi et al. · JNCI Journal of the National Cancer Institute · 2014 · 408 citations · Full text

, , +17

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Richard S. Finn, Judy Dering, Charles Ginther et al. · Breast Cancer Research and Treatment · 2007 · 403 citations · Full text

, , +17

Activated Phosphoinositide 3-Kinase/AKT Signaling Confers Resistance to Trastuzumab but not Lapatinib

Neil A. O’Brien, Brigid C. Browne, Lucy Chow et al. · Molecular Cancer Therapeutics · 2010 · 337 citations

, , +17

Expression of p16 and Retinoblastoma Determines Response to CDK4/6 Inhibition in Ovarian Cancer

Gottfried E. Konecny, Boris Winterhoff, Teodora Kolarova et al. · Clinical Cancer Research · 2011 · 303 citations

, , +17

1–5 of 34